India NCLT Insolvency Resolution Filings — September 10, 2026
The Indian corporate insolvency landscape is witnessing a bifurcation between distressed asset resolution and strategic acquisitions, with four filings today highlighting divergent outcomes. VXL Instruments' approved resolution plan results in near-total equity wipeout for public shareholders (retaining only 5% stake), reflecting a typical IBC outcome for companies with negative net worth of ₹5.31 Crore. In contrast, JSW Infrastructure's acquisition of NCR Rail for ₹467.47 Crore plus land costs demonstrates how infrastructure players are using the IBC route for inorganic growth, despite NCR Rail's accumulated losses of ₹2,168.69 Crore. Shilpa Medicare's subsidiary FTF Pharma entering CIRP over a ₹2.18 Crore operational debt signals contagion risk in the pharmaceutical supply chain, while Sammaan Capital's demerger scheme vote highlights the procedural complexities of NCLT-driven corporate restructuring. A key portfolio-level trend is the increasing participation of strategic acquirers (like JSW Infrastructure) in IBC proceedings, which is driving higher resolution values but also creating complex capital structures.